(Q37931336)

25 August 2017

1 reference

title

Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review (English)

1 reference

25 August 2017

0 references

0 references

1 reference

1 reference

M E Hellemons

1

1 reference

25 August 2017

J Kerschbaum

2

1 reference

25 August 2017

S J L Bakker

3

1 reference

25 August 2017

H Neuwirt

4

1 reference

25 August 2017

B Mayer

5

1 reference

25 August 2017

G Mayer

6

1 reference

25 August 2017

D de Zeeuw

7

1 reference

25 August 2017

H J Lambers Heerspink

8

1 reference

25 August 2017

M Rudnicki

9

1 reference

25 August 2017

1 May 2012

1 reference

25 August 2017

1 reference

25 August 2017

29

1 reference

25 August 2017

567-577

1 reference

25 August 2017

5

1 reference

The health care costs of diabetic nephropathy in the United States and the United Kingdom.

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Screening for albuminuria identifies individuals at increased renal risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Biomarkers of cardiovascular disease: molecular basis and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Technology Insight: biomarker development in acute kidney injury--what can we anticipate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Integrating the predictiveness of a marker with its performance as a classifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Diabetic kidney disease in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Racial differences in the incidence and progression of renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Systematic review on urine albumin testing for early detection of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

Assessing the performance of prediction models: a framework for traditional and novel measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

A new logistic regression approach for the evaluation of diagnostic test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03437.X

10.1111/J.1464-5491.2011.03437.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference